Therefore, following the rationale, it seems logical that maintaining low levels of CD73 expression would culminate in reduced levels of extracellular ADO and, consequently, lower levels of intracellular ADO providing an advantage in terms of survival and proliferation to tumour cells. This evidence concerns the gene NT5E and neoplasm.